HUMACYTE INC. - COMMO

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024

06 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024

26 3月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update

22 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024

18 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference

01 3月 2024 09:16:19 条件 Nasdaq GlobeNewswire

Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock

29 2月 2024 21:18:05 条件 Nasdaq GlobeNewswire

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

29 2月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

09 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma

12 12月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference

24 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma

17 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Humacyte Third Quarter 2023 Financial Results and Business Update

09 11月 2023 16:01:00 条件 Nasdaq GlobeNewswire

Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 9, 2023

02 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Humacyte Publishes Preclinical Results Showing Human Acellular Vessel™ (HAV™) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model

16 10月 2023 08:55:42 条件 Nasdaq GlobeNewswire

Humacyte to Present at the Cantor Global Healthcare Conference

21 9月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023

18 9月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) in Treatment of Patients with Vascular Trauma

12 9月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel™ (HAV™) Tuesday, September 12, 2023 at 8:00 AM ET

11 9月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Results From Mayo Clinic Clinical Study of Humacyte’s Human Acellular Vessel™ (HAV™) in Treatment of Patients with Chronic Limb Ischemia Presented at Midwestern Vascular Conference

11 9月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Humacyte Presents Clinical Performance of Human Acellular Vessel™ (HAV™) From Ukrainian Humanitarian Program

15 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire